Vaccine trial in humans as hopeful | COVID-19


Covid vaccine to be safe in India Those who have been tested for the Ad5 – Encove vaccine have rapidly gained immunity, according to a leading health publication in the journal The Lancet.

The study was led by Professor Fengchai Shu of the Jiangsu Provincial Center for Disease Control in China. The vaccine was administered to 108 people aged 18–60 in Wuhan, the epicenter of Kovid. Among them, an antibody against the Sars Cove-2 virus was developed.

The study also calls for more research into whether the vaccine can cause side effects. Those who received the vaccine had seen a positive outcome within 28 days and the final outcome in 6 months.

English Summary: Corona vaccine test

Source link


Please enter your comment!
Please enter your name here